Hey everybody, Dave Bartosiak with Trending Stocks at Zacks.com. There is every reason to think that in the coming years Mars and its mysteries will become increasingly familiar to the inhabitants of the Planet Earth. That was my best Carl Sagan impression. If you don’t know who that is, google it. Rising from the post-pandemic ashes, private companies have their eyes on the skies. Way up in fact, to Mars.
There are now a host of companies involved in the new space race. There are space tourism companies like Virgin Galactic SPCE, there are satellite technology companies like Maxar MAXR and Iridium IRDM and plenty of others which offer technologies valuable to NASA’s Jet Propulsion Lab. Just today, Lightpath Technologies LPTH announced it plans to participate in the Mars Exploration Program. There’s even a Space ETF, with the appropriately named ticker, UFO.
Which of these stocks has staying power beyond the headlines? Let’s take a closer look here on Zacks.com to find out…
Every time you share this video, Marvin the Martian narrowly misses Earth with his Illudium Q-36 Explosive Space Modulator. Checkout Zacks.com/promo for this week’s promotion on Blockchain Innovators, run by the most ruggedly handsome man at Zacks. Be sure to Follow the Author, subscribe to the YouTube channel, Twitter @bartosiastics, and come back for all the action with Zacks.com, I’m Dave Bartosiak.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.
Find us at the office
Chappa- Adamitis street no. 38, 81811 Tripoli, Libya
Give us a ring
+69 213 130 910
Mon - Fri, 10:00-22:00